Mice ascites as a source of polyclonal and monoclonal antibodies-Reference-Cited by-同舟云学术

Mice ascites as a source of polyclonal and monoclonal antibodies

Published:1993-05 Issue:2 Volume:161 Page:187-192
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Mahana W.,Paraf A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference14 articles.

1. Apparent discrepancies between immunochemical methods used for ovalbumin recognition in food;Breton;J. Sci. Food Agric.,1989

2. Development of transplantable ascites tumours which continuously produce polyclonal antibodies in pristane primed BALB/c mice immunized with bacterial antigens and complete Freund's adjuvant;Cevenini;J. Immunol. Methods,1991

3. IgA Hybridomas: a method for generation in high numbers;Colwell;J. Immunol. Methods,1982

4. The production of hybridomas from the gut associated lymphoid tissue of tumour rats. I. Mesenteric nodes as a source of IgG producing cells;Dean;Clin. Exp. Immunol.,1984

5. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell line;Kearney;J. Immunol.,1979

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a colloidal gold immunochromatographic strip for the simultaneous detection of porcine epidemic diarrhea virus and transmissible gastroenteritis virus;Frontiers in Microbiology;2024-06-19

2. Production of Polyclonal Antibodies;Making and Using Antibodies;2013-06-17

3. Lectin-aided separation of circulating tumor cells and assay of their response to an anticancer drug in an integrated microfluidic device;ELECTROPHORESIS;2010-09-20

4. Production of Polyclonal Antibodies;Making and Using Antibodies;2006-12-13

5. Gene expression in the LNCaP human prostate cancer progression model: Progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo;Cancer Letters;2006-12